54166-15-3

Basic information

• Product Name: 3-BENZYLOXYCYCLOBUTANE-1,1-DICARBOXYLIC ACID DIETHYL ESTER
• Synonyms: 3-BENZYLOXYCYCLOBUTANE-1,1-DICARBOXYLIC ACID DIETHYL ESTER;diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate;1,1-Cyclobutanedicarboxylic acid, 3-(phenylMethoxy)-, 1,1-diethyl ester;3-Benzyloxycyclobutane-1,...;Diethyl 3-benzyloxy-1,1-cyclobutanedicarboxylate;1,1-diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate;3-Benzyloxycyclobutane-1,1-dicarboxylic acid diethyl ester - SB8166
• CAS NO: 54166-15-3
• Molecular Formula: C₁₇H₂₂O₅
• Molecular Weight: 306.35
• Mol File: 54166-15-3.mol
• Article Data: 29

Chemical Properties

• Boiling Point: 368.3 °C at 760 mmHg
• Flash Point: 158.2 °C
• Appearance: /
• Density: 1.15 g/cm³
• Vapor Pressure: 1.29E-05mmHg at 25°C
• Refractive Index: 1.523
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-BENZYLOXYCYCLOBUTANE-1,1-DICARBOXYLIC ACID DIETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BENZYLOXYCYCLOBUTANE-1,1-DICARBOXYLIC ACID DIETHYL ESTER(54166-15-3)
• EPA Substance Registry System: 3-BENZYLOXYCYCLOBUTANE-1,1-DICARBOXYLIC ACID DIETHYL ESTER(54166-15-3)

Safety Data

• Hazardous Substances Data: 54166-15-3(Hazardous Substances Data)

Usage

General Description

3-Benzyloxycyclobutane-1,1-dicarboxylic Acid Diethyl Ester is a synthetic chemical compound. As the name suggests, it belongs to the class of organic compounds known as benzyloxycyclobutane carboxylic esters, which are characterized by a benzyloxy group attached to a cyclobutane ring and two carboxylic acid ester functionalities. This chemical is largely utilized in the field of organic chemistry as a reagent or intermediate for the synthesis of other complex organic molecules, although specific applications can vary. Detailed properties such as its physical appearance, melting or boiling points, or toxicity are not widely documented, indicating its specific use in specialized research.

InChI:InChI=1/C17H22O5/c1-3-20-15(18)17(16(19)21-4-2)10-14(11-17)22-12-13-8-6-5-7-9-13/h5-9,14H,3-4,10-12H2,1-2H3

Upstream product

• 1356087-23-4 C₁₇H₂₃ClO₅ 
• 100-39-0 benzyl bromide 
• 105-53-3 diethyl malonate 
• 54307-67-4 1-bromo-2-benzyloxy-3-chloropropane 
• 35995-55-2 (2-bromo-1-bromomethylethoxymethyl)benzene 

Downstream Products

• 191110-48-2 3-benzyloxycyclobutane-1,1-dicarboxamine 
• 222727-29-9 1-amino-3-benzyloxycyclobutane-1-carboxylic acid 
• 191110-49-3 2-(benzyloxy)-5,7-diazaspiro[3.4]octane-6,8-dione 
• 222727-31-3 1-t-butyl carbamate-3-benzyloxy-1-cyclobutane-1-carboxylic acid 
• 222727-33-5 1-t-butyl carbamate-3-benzyloxy-1-cyclobutane-1-carboxylic acid methyl ester 
• 4934-99-0 methylester of 3-hydroxycyclobutane-1-carboxylic acid 
• 4934-98-9 methylester of 3-benzyloxycyclobutane-1-carboxylic acid 
• 344348-50-1 amide of 3-p-toluenesulfonyloxycyclobutane-1-carboxylic acid 
• 344338-13-2 methylester of 3-p-toluenesulfonyloxycyclobutane-1-carboxylic acid 
• 74307-75-8 (1r,3r)-3-aminocyclobutane-1-carboxylic acid 
• 74316-27-1 cis-3-aminocyclobutane-1-carboxylic acid 
• 84182-59-2 hydrochloride of cis-3-aminocyclobutane-1-carboxylic acid 

Relevant articles and documents

Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand

Two platinum(II) complexes, DN603 and DN604, were designed and prepared by using 3-oxocyclobutane-1,1-dicarboxylate as a ligand. The compounds were prepared according to the concept that incorporation of a functionalized moiety in the leaving ligand that

Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems

We describe herein the synthesis of a series of carboplatin derivatives with different functional groups at position 3 of the cyclobutane ring. This pharmacomodulation approach aims at facilitating the vectorisation of these analogues, via their subsequen

BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C

The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.